2025-2026 Regular Session • Iowa Legislature
SF433
Legislative Summary
A bill for an act relating to direct acting antiviral medications, including prior authorization requirements, and the Iowa medical assistance drug utilization review commission.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/25/2025
Introduced, referred to Health and Human Services. S.J. 353.
Senate
3/3/2025
Subcommittee: Klimesh, Costello, and Wahls. S.J. 393.
Senate
Status Information
Current Status
Introduced(2/25/2025)
Chamber
Senate
Committee
Health and Human Services(Senate)
Sponsors
Democrat: 1
Primary Sponsor
Zach Wahls
Democrat